Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Goodwill (2018 - 2025)

Ptc Therapeutics has reported Goodwill over the past 8 years, most recently at $82.3 million for Q4 2025.

  • Quarterly results put Goodwill at $82.3 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $82.3 million (changed 0.0% YoY), and the annual figure for FY2025 was $82.3 million, changed 0.0%.
  • Goodwill for Q4 2025 was $82.3 million at Ptc Therapeutics, roughly flat from $82.3 million in the prior quarter.
  • Over the last five years, Goodwill for PTCT hit a ceiling of $82.3 million in Q1 2021 and a floor of $82.3 million in Q2 2024.
  • Median Goodwill over the past 5 years was $82.3 million (2021), compared with a mean of $82.3 million.
  • Biggest five-year swings in Goodwill: rose 0.05% in 2021 and later decreased 0.05% in 2024.
  • Ptc Therapeutics' Goodwill stood at $82.3 million in 2021, then changed by 0.0% to $82.3 million in 2022, then changed by 0.0% to $82.3 million in 2023, then changed by 0.0% to $82.3 million in 2024, then changed by 0.0% to $82.3 million in 2025.
  • The last three reported values for Goodwill were $82.3 million (Q4 2025), $82.3 million (Q3 2025), and $82.3 million (Q2 2025) per Business Quant data.